This is a StreetInsider.com Premium Only Page

Adaptive Biotechnologies (ADPT) – StreetInsider.com Reports

Apr 4, 2024 06:40 AM Adeptus Biotechnologies Corp. (ADPT) PT Lowered to $5 at BTIG, 'assign a lower valuation to the businesses'

Apr 2, 2024 04:14 PM Adaptive Biotechnologies (ADPT) Announces CFO Resignation

Feb 20, 2024 04:55 AM Adeptus Biotechnologies Corp. (ADPT) PT Lowered to $6 at BTIG

Feb 16, 2024 06:41 AM Adeptus Biotechnologies Corp. (ADPT) PT Lowered to $5 at Goldman Sachs

Feb 15, 2024 07:54 AM Adeptus Biotechnologies Corp. (ADPT) PT Lowered to $8 at JPMorgan

Feb 14, 2024 04:24 PM Adaptive Biotechnologies (ADPT) Misses Q4 EPS by 18c

Nov 16, 2023 07:11 AM Adeptus Biotechnologies Corp. (ADPT) PT Lowered to $10 at Scotiabank

Nov 10, 2023 07:53 AM Adeptus Biotechnologies Corp. (ADPT) PT Lowered to $11 at JPMorgan

Nov 10, 2023 06:07 AM Adeptus Biotechnologies Corp. (ADPT) PT Lowered to $7 at BTIG

Nov 9, 2023 04:38 PM Adaptive Biotechnologies (ADPT) Misses Q3 EPS by 1c

Oct 24, 2023 08:26 AM Adeptus Biotechnologies Corp. (ADPT) PT Lowered to $10 at Morgan Stanley

Oct 20, 2023 09:09 AM Adeptus Biotechnologies Corp. (ADPT) PT Lowered to $9 at BofA Securities

Oct 16, 2023 06:58 AM Adeptus Biotechnologies Corp. (ADPT) PT Raised to $14 at Piper Sandler

Sep 13, 2023 07:31 AM Adaptive Biotechnologies (ADPT) Announces Launch of Epic Integration for clonoSEQ

Aug 8, 2023 08:53 AM Adeptus Biotechnologies Corp. (ADPT) PT Lowered to $14 at Piper Sandler

Aug 4, 2023 08:14 AM Adeptus Biotechnologies Corp. (ADPT) PT Lowered to $13 at Morgan Stanley

Aug 3, 2023 05:38 AM Adeptus Biotechnologies Corp. (ADPT) PT Lowered to $12 at JPMorgan

Aug 3, 2023 05:00 AM Adeptus Biotechnologies Corp. (ADPT) PT Lowered to $11 at BTIG

Aug 2, 2023 04:36 PM Adaptive Biotechnologies (ADPT) Tops Q2 EPS by 2c; Offers FY23 Revenue Guidance

Aug 2, 2023 04:09 PM Adaptive Biotechnologies (ADPT) Tops Q2 EPS by 2c; Offers FY23 Revenue Guidance

Jul 5, 2023 04:18 AM JPMorgan Assumes Adeptus Biotechnologies Corp. (ADPT) at Overweight

May 9, 2023 07:31 AM Adaptive Biotechnologies (ADPT) Announces FDA Acceptance of Genentech’s Investigational New Drug Application for the First Neoantigen-Directed T-Cell Therapy Product in Oncology

May 8, 2023 08:26 AM Adeptus Biotechnologies Corp. (ADPT) PT Raised to $15 at Piper Sandler

May 5, 2023 09:17 AM Adeptus Biotechnologies Corp. (ADPT) PT Lowered to $14 at Morgan Stanley

Apr 12, 2023 07:31 AM Adaptive Biotechnologies (ADPT) Announces Collaboration with Takeda (TAK) to Measure Minimal Residual Disease with clonoSEQ Assay

Feb 15, 2023 09:23 AM Adeptus Biotechnologies Corp. (ADPT) PT Raised to $11 at BofA Securities

Feb 14, 2023 04:14 PM Adaptive Biotechnologies (ADPT) Tops Q4 EPS by 7c

Jan 4, 2023 04:45 PM Scotiabank Starts Adeptus Biotechnologies Corp. (ADPT) at Sector Outperform

Jan 4, 2023 10:37 AM Adeptus Biotechnologies Corp. (ADPT) PT Lowered to $10 at BofA Securities

Dec 21, 2022 03:41 PM Today's most important upgrades

Dec 21, 2022 04:09 AM Piper Sandler Upgrades Adeptus Biotechnologies Corp. (ADPT) to Overweight

Nov 7, 2022 05:16 AM Adeptus Biotechnologies Corp. (ADPT) PT Lowered to $13 at BTIG

Nov 4, 2022 01:21 PM Adeptus Biotechnologies Corp. (ADPT) PT Lowered to $16 at Morgan Stanley

Nov 3, 2022 04:18 PM Adaptive Biotechnologies (ADPT) Tops Q3 EPS by 6c

Oct 27, 2022 08:42 AM Adeptus Biotechnologies Corp. (ADPT) PT Lowered to $14 at BTIG

Oct 26, 2022 06:56 AM Adeptus Biotechnologies Corp. (ADPT) PT Lowered to $7.50 at Piper Sandler

Oct 11, 2022 08:05 AM Adaptive Biotechnologies (ADPT) Partners with Epic to Increase Access to Minimal Residual Disease (MRD) Monitoring in Blood Cancers

Sep 12, 2022 08:31 AM Adaptive Biotechnologies (ADPT) Announces Non-Dilutive Royalty Financing with OrbiMed for Up to $250 Million

Aug 24, 2022 04:09 PM Credit Suisse Starts Adeptus Biotechnologies Corp. (ADPT) at Underperform

Aug 5, 2022 05:49 AM Adeptus Biotechnologies Corp. (ADPT) PT Lowered to $17 at BTIG

Aug 4, 2022 10:02 AM Adeptus Biotechnologies Corp. (ADPT) PT Lowered to $17 at Morgan Stanley

Aug 3, 2022 04:09 PM Adaptive Biotechnologies (ADPT) Tops Q2 EPS by 6c; Offers FY22 Revenue Guidance

Jun 15, 2022 07:30 AM Adaptive Biotechnologies (ADPT) Launches T-Detect Lyme for Detection of Early Lyme Disease

Jun 3, 2022 06:24 AM Piper Sandler Starts Adeptus Biotechnologies Corp. (ADPT) at Neutral

May 5, 2022 04:56 PM Adeptus Biotechnologies Corp. (ADPT) PT Lowered to $18 at Morgan Stanley

May 5, 2022 06:39 AM Adeptus Biotechnologies Corp. (ADPT) PT Lowered to $25 at BTIG

May 4, 2022 04:56 PM Adaptive Biotechnologies (ADPT) Tops Q1 EPS by 1c

Mar 9, 2022 07:00 AM Adaptive Biotechnologies (ADPT) Appoints Tycho Peterson as CFO

Feb 18, 2022 11:35 AM Adaptive Biotechnologies (ADPT) Announces New Data Demonstrating ImmunoSEQ® Technology Can Identify T-Cell Receptors Associated with Crohn’s Disease

Feb 16, 2022 07:22 AM Adeptus Biotechnologies Corp. (ADPT) PT Lowered to $21 at Goldman Sachs